insights_auto
Prečo akcie LCTX klesli 3,50%?
Preskúmať podrobnejšiechevron_right
LCTX:NYSEAMERICAN
Lineage Cell Therapeutics Inc
0,99 USD
arrow_downward
-3,50%(-0,036) 1 d.
0,98 USD
arrow_downward
-1,40% (-0,014)bedtimePo uzavretí
Zavreté: 9. 10., 16:00:00 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre LCTX…
Otvoriť
1,02 USD
Vysoká
1,02 USD
Nízka
0,98 USD
Trh. kap.
251,39 mil.
Priem. obj.
1,41 mil.
Objem
1,16 mil.
Max. za 52 týž.
2,09 USD
Min. za 52 týž.
0,88 USD
Výnosy na akciu
-0,14 USD
Beta
1,60
Akcie v obehu
252,91 mil.
Počet zamestnancov
75
Otvoriť
1,02 USD
Vysoká
1,02 USD
Nízka
0,98 USD
Trh. kap.
251,39 mil.
Priem. obj.
1,41 mil.
Objem
1,16 mil.
Max. za 52 týž.
2,09 USD
Min. za 52 týž.
0,88 USD
Výnosy na akciu
-0,14 USD
Beta
1,60
Akcie v obehu
252,91 mil.
Počet zamestnancov
75
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Yahoo Finance
·
pred 10 minútami
Beyond S&P 500 Index Funds: Here's the 1 Sector I'd Buy First as a New Investor
Cryptonews.net
·
pred 6 minútami
Crypto's Next Big Opportunity? Nasdaq CEO Highlights Tokenization's Billion-Dollar Potential
The Globe and Mail
·
pred 1 hodinou
The S&P 500 Just Hit a Record High -- Here's How Much Higher It Can Climb, According to the Wall Street Consensus
24/7 Wall St.
·
pred 4 hodinami
KLA Turned $1,000 Into $31,595 in a Decade, Crushing the S&P 500 by 8.7x
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Informácie o subjekte Lineage Cell Therapeutics Inc